by Usha Govindarajulu | Oct 29, 2020 | Epidemiology, Healtcare, Usha Govindarajulu
Recently, the FDA deemed Remdesivir as a treatment for COVID-19, the first treatment approved as such. Back on May 1, they had granted EUA, emergency use authorization, of Remdesivir for COVID-19 and many hospitals made use of it, especially given that there was very...
by Usha Govindarajulu | Oct 13, 2020 | Healtcare, New York, Usha Govindarajulu
In the last several weeks, though New Yorkers have been enjoying things slowly reopening and having a little more freedom to go out and about and enjoy outdoor dining with indoor dining around the corner and gyms reopened, cases slowly started rising again. At...
by Usha Govindarajulu | Sep 29, 2020 | Epidemiology, Healtcare, Professor
What makes someone have lasting immunity to COVID-19? This is a burning question in order to understand how to protect against the virus and sustain immunity. This also has implications for the various vaccines that are either in development or in testing phases. ...
by Usha Govindarajulu | Sep 15, 2020 | Blog, Epidemiology, Healtcare, New York, Professor, Usha Govindarajulu
New York City had been the an epicenter of the pandemic in the United States in the spring from March to May until cases and hospitalizations started dipping. Now NYC is now longer an epicenter after having gone through this first wave while many other parts of the...
by Usha Govindarajulu | Sep 1, 2020 | Blog, Epidemiology, Healtcare, Usha Govindarajulu
COVID-19 testing is complex with different types and different ways of being tested put in place. Even then, the testing has also changed over time to become more refined and/or faster all at the same time. Of course, this may be confusing to the general public about...
